New York State Teachers Retirement System (NYSTRS)’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
Other funds holding TVRD
DGI
FCM
C
BCLSI
New York State Teachers Retirement System (NYSTRS)'s TVRD Position: Q2 2023 in Review
New York State Teachers Retirement System (NYSTRS) sold out of Tvardi Therapeutics (TVRD) in Q2 2023, closing a stake of 2,401 shares — an estimated $424K sold.
New York State Teachers Retirement System (NYSTRS) first reported a position in TVRD in Q2 2021 and held it in 8 quarters. The position peaked at $927K in Q4 2022. 137 funds tracked by Wall St. Rank hold TVRD as of Q2 2023.
- New York State Teachers Retirement System (NYSTRS) reported no remaining Tvardi Therapeutics position as of Q2 2023 after selling out during the quarter.
- New York State Teachers Retirement System (NYSTRS) sold 2,401 Tvardi Therapeutics shares in Q2 2023, an estimated $424K.
- New York State Teachers Retirement System (NYSTRS) first reported a position in Tvardi Therapeutics in Q2 2021 and held it in 8 quarters.
- New York State Teachers Retirement System (NYSTRS)'s Tvardi Therapeutics position peaked at $927K in Q4 2022.
- 137 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2023.
Based on New York State Teachers Retirement System (NYSTRS)'s 13F filing for Q2 2023, filed 27 Jul 2023.